CVS HEALTH REPORTS FOURTH QUARTER AND FULL-YEAR 2023 RESULTS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
CVS Health (CVS) cuts full-year profit outlook
February 7, 2024 6:44 AM ESTCVS Health (NYSE: CVS) unveiled financial results for the fourth quarter and reduced its earnings outlook for 2024.
The stock initially fell in premarket trading before bouncing back into the green.
For FQ4 2023, the company reported earnings per share (EPS) of $2.12, topping the consensus... More
CVS Health (CVS) Tops Q4 EPS by 14c; Trims Outlook
February 7, 2024 6:33 AM ESTCVS Health (NYSE: CVS) reported Q4 EPS of $2.12, $0.14 better than the analyst estimate of $1.98. Revenue for the quarter came in at $93.81 billion versus the consensus estimate of $90.25 billion.
GUIDANCE:
CVS Health sees FY2024 EPS of at least $8.30, versus... More
